149 related articles for article (PubMed ID: 11190907)
1. Synthetic heparin pentasaccharide depolymerization by heparinase I: molecular and biological implications.
Daud AN; Ahsan A; Iqbal O; Walenga JM; Silver PJ; Ahmad S; Fareed J
Clin Appl Thromb Hemost; 2001 Jan; 7(1):58-64. PubMed ID: 11190907
[TBL] [Abstract][Full Text] [Related]
2. Heparinase I acts on a synthetic heparin pentasaccharide corresponding to the antithrombin III binding site.
Yu G; LeBrun L; Gunay NS; Hoppensteadt D; Walenga JM; Fareed J; Linhardt RJ
Thromb Res; 2000 Dec; 100(6):549-56. PubMed ID: 11152935
[TBL] [Abstract][Full Text] [Related]
3. Effect of new synthetic heparin mimetics on whole blood thrombin generation in vivo and in vitro in rats.
Hérault JP; Bernat A; Gaich C; Herbert M
Thromb Haemost; 2002 Feb; 87(2):238-44. PubMed ID: 11858483
[TBL] [Abstract][Full Text] [Related]
4. Cleavage of the antithrombin III binding site in heparin by heparinases and its implication in the generation of low molecular weight heparin.
Shriver Z; Sundaram M; Venkataraman G; Fareed J; Linhardt R; Biemann K; Sasisekharan R
Proc Natl Acad Sci U S A; 2000 Sep; 97(19):10365-70. PubMed ID: 10984532
[TBL] [Abstract][Full Text] [Related]
5. Combination of a two-step fluorescence assay and a two-step anti-Factor Xa assay for detection of heparin falsifications and protein in heparins.
Alban S; Lühn S; Schiemann S
Anal Bioanal Chem; 2011 Jan; 399(2):681-90. PubMed ID: 20953779
[TBL] [Abstract][Full Text] [Related]
6. Synthetic analogues of the antithrombin III-binding pentasaccharide sequence of heparin. Prediction of in vivo residence times.
van Amsterdam RG; Vogel GM; Visser A; Kop WJ; Buiting MT; Meuleman DG
Arterioscler Thromb Vasc Biol; 1995 Apr; 15(4):495-503. PubMed ID: 7749861
[TBL] [Abstract][Full Text] [Related]
7. Hexasaccharides from the histamine-modified depolymerization of porcine intestinal mucosal heparin.
Chuang WL; McAllister H; Rabenstein DL
Carbohydr Res; 2002 May; 337(10):935-45. PubMed ID: 12007476
[TBL] [Abstract][Full Text] [Related]
8. Antithrombotic activity of a synthetic heparin pentasaccharide in a rabbit stasis thrombosis model using different thrombogenic challenges.
Walenga JM; Petitou M; Lormeau JC; Samama M; Fareed J; Choay J
Thromb Res; 1987 Apr; 46(2):187-98. PubMed ID: 3603420
[TBL] [Abstract][Full Text] [Related]
9. Introducing a C-interglycosidic bond in a biologically active pentasaccharide hardly affects its biological properties.
Petitou M; Hérault JP; Lormeau JC; Helmboldt A; Mallet JM; Sinaÿ P; Herbert JM
Bioorg Med Chem; 1998 Sep; 6(9):1509-16. PubMed ID: 9801822
[TBL] [Abstract][Full Text] [Related]
10. Biologic studies on chemically synthesized pentasaccharide and tetrasaccharide fragments.
Choay J
Semin Thromb Hemost; 1985 Apr; 11(2):81-5. PubMed ID: 4035368
[TBL] [Abstract][Full Text] [Related]
11. Structural studies on the bacterial lyase-resistant tetrasaccharides derived from the antithrombin III-binding site of porcine intestinal heparin.
Yamada S; Yoshida K; Sugiura M; Sugahara K; Khoo KH; Morris HR; Dell A
J Biol Chem; 1993 Mar; 268(7):4780-7. PubMed ID: 8444855
[TBL] [Abstract][Full Text] [Related]
12. The antithrombotic efficacy of the GP IIb/IIIa antagonist SR121787 is potentiated by antithrombin-dependent factor Xa inhibition without an increase in the bleeding risk in the rabbit.
Bernat A; Savi P; Lale A; Hoffmann P; Herbert JM
J Cardiovasc Pharmacol; 1999 Apr; 33(4):573-9. PubMed ID: 10218727
[TBL] [Abstract][Full Text] [Related]
13. Chromatographic methods for product-profile analysis and isolation of oligosaccharides produced by heparinase-catalyzed depolymerization of heparin.
Chuang WL; McAllister H; Rabenstein L
J Chromatogr A; 2001 Oct; 932(1-2):65-74. PubMed ID: 11695869
[TBL] [Abstract][Full Text] [Related]
14. Mechanism of heparin activation of antithrombin: evidence for an induced-fit model of allosteric activation involving two interaction subsites.
Desai UR; Petitou M; Björk I; Olson ST
Biochemistry; 1998 Sep; 37(37):13033-41. PubMed ID: 9737884
[TBL] [Abstract][Full Text] [Related]
15. Pentasaccharide Org31540/SR90107A clinical trials update: lessons for practice.
Turpie AG
Am Heart J; 2001 Aug; 142(2 Suppl):S9-15. PubMed ID: 11479485
[TBL] [Abstract][Full Text] [Related]
16. Controllable production of low molecular weight heparins by combinations of heparinase I/II/III.
Wu J; Zhang C; Mei X; Li Y; Xing XH
Carbohydr Polym; 2014 Jan; 101():484-92. PubMed ID: 24299802
[TBL] [Abstract][Full Text] [Related]
17. Structural studies on the tri- and tetrasaccharides isolated from porcine intestinal heparin and characterization of heparinase/heparitinases using them as substrates.
Yamada S; Sakamoto K; Tsuda H; Yoshida K; Sugahara K; Khoo KH; Morris HR; Dell A
Glycobiology; 1994 Feb; 4(1):69-78. PubMed ID: 8186552
[TBL] [Abstract][Full Text] [Related]
18. A new synthetic pentasaccharide with increased anti-factor Xa activity: possible role for anionic clusters in the interaction of heparin and antithrombin III.
Petitou M; Lormeau JC; Choay J
Semin Thromb Hemost; 1991; 17 Suppl 2():143-6. PubMed ID: 1948084
[No Abstract] [Full Text] [Related]
19. Antifactor Xa activity and antithrombotic activity in rats of structural analogues of the minimum antithrombin III binding sequence: discovery of compounds with a longer duration of action than of the natural pentasaccharide.
Meuleman DG; Hobbelen PM; Van Dinther TG; Vogel GM; Van Boeckel CA; Moelker HC
Semin Thromb Hemost; 1991; 17 Suppl 1():112-7. PubMed ID: 2068564
[TBL] [Abstract][Full Text] [Related]
20. Examination, by 1H-n.m.r. spectroscopy, of the binding of a synthetic, high-affinity heparin pentasaccharide to human antithrombin III.
Gettins P; Choay J
Carbohydr Res; 1989 Jan; 185(1):69-76. PubMed ID: 2713873
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
